A striking finding from recent pharmacological research demonstrates the lingering presence of caffeine in certain individuals: approximately 100 mg—equivalent to half a cup of coffee—remains circulating in slow metabolizers’ bloodstreams at bedtime following a 2 PM consumption. This residual caffeine actively interferes with sleep architecture while the individual attempts to rest.
The determining factor is the CYP1A2 gene variant, which controls caffeine metabolism speed. Slow metabolizers, representing 10–15% of the population, retain caffeine far longer than their fast-metabolizer counterparts. Beyond sleep disruption, this accumulation carries cardiovascular implications: slow metabolizers show elevated risk for myocardial infarction and hypertension at high caffeine doses. Conversely, fast metabolizers demonstrate neutral or even protective cardiovascular associations. These findings underscore why personalized caffeine guidance based on genotyping may prove more valuable than universal dietary recommendations.
Read the full article on GMJ Newsroom.
Was this article helpful?
GMJ Brief · Key Finding
📰 Read the full article: Caffeine Does Not Create Energy—It Masks Fatigue, Study Shows →
